Shah, Parth

Shah, Parth was paid $269K by Medicaid between Jan 2018 and Nov 2024, across 25 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 84% of everything it billed.

33Billing provider infoSHAH, PARTH
NEWBURGH, NY 12550

33aNPI1093958613assigned 04/13/2009

33bProvider typeFamily Medicine Physician

28Total paid$269K

24GClaims5,280

24DCodes billed25

24AFirst – last monthJan 2018 – Nov 2024

Compared with peers

Next to other Family Medicine Physician providers in New York

Rank by total paid#343 of 2,605

Median peer was paid$10K

This provider vs. median27×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	204	$12K
2019	783	$34K
2020	786	$35K
2021	1,155	$69K
2022	1,578	$86K
2023	494	$24K
2024incomplete	280	$9K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	84%	2,753	2,531	$228K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	5.2%	230	220	$14K
80050	General health panel	2.1%	145	145	$6K
96127		1.3%	732	723	$3K
99395	Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years	1.3%	27	27	$3K
80061	Lipid panel	1.1%	241	241	$3K
83036	Hemoglobin; glycosylated (A1C)	<1%	288	288	$3K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	15	14	$2K
90686		<1%	129	128	$2K
99396	Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years	<1%	12	12	$2K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	128	127	$1K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	13	12	$975.00

13 more codes

86803		<1%	26	$354.23
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	14	$337.12
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	14	$325.90
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	13	$325.00
99406		<1%	12	$190.60
82607		<1%	13	$167.50
36415	Collection of venous blood by venipuncture	<1%	184	$143.92
80053	Comprehensive metabolic panel	<1%	13	$105.60
96160		<1%	147	$61.69
99401		<1%	13	$31.00
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established)	0%	82	$0.00
3078F		0%	17	$0.00
3074F		0%	19	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.